ADAR1 Capital Management »

Danaher Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Danaher Corporation (DHR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Danaher Corporation

Tip: Access up to 7 years of quarterly data

All positions including Danaher Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Danaher Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.9M 26k 228.92
2024-12-31 $918k 4.0k 229.55

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Danaher Corporation

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
FMR
Geode Capital Management
Wellington Management Company
Norges Bank Investment Management
Generation Investment Management
Northern Trust
Henderson Group
Eagle Capital Management
Nuveen
Ubs Global Asset Management Americas

View all funds holding Danaher Corporation